Skip to main content
CDC Website

Government Agencies

Progress Toward Elimination of Mother-to-Child Transmission of Hepatitis B Virus — Region of the Americas, 2012–2022

This report outlines progress toward eliminating mother-to-child transmission of hepatitis B virus (HBV) in the Americas from 2012 to 2022. It highlights improvements in vaccination coverage, including birth doses, but also notes coverage declines in some countries, which could hinder elimination goals. The report emphasizes the need for maintaining high vaccination rates, expanding hepatitis B testing for pregnant women, and ensuring timely treatment for newborns.

Researchers Reveal Why a Key Tuberculosis Drug Works Against Resistant Strains

This article highlights groundbreaking research on tuberculosis (TB) treatment, revealing why a key TB drug remains effective against resistant strains. Rutgers Health researchers uncover the molecular mechanisms that enable this drug to combat TB bacteria, potentially inspiring improved treatments and drug development strategies. The findings emphasize the need for continued research to address antibiotic resistance and enhance global TB control efforts.

Study Finds Lack of Testing for Gonorrhea, Chlamydia During Pregnancy

This webpage highlights a recent study that reveals gaps in gonorrhea and chlamydia testing during pregnancy. It emphasizes the potential health risks these infections pose to both mother and child, urging the need for improved screening protocols. The study underscores the importance of regular prenatal testing to ensure better health outcomes for both.

What You Need to Know About the New Hepatitis C Test

This article highlights a new hepatitis C test that delivers rapid results without requiring a separate lab visit, improving access to early diagnosis and treatment. It emphasizes the importance of expanding testing efforts, particularly for high-risk populations, to support hepatitis C elimination. The article underscores the need for continued innovation in screening technologies to reduce barriers to care and prevent long-term health complications like liver disease and cancer.

Global Tuberculosis Report 2024

The WHO Global tuberculosis report 2024 provides a comprehensive and up-to-date assessment of the TB epidemic and of progress in prevention, diagnosis and treatment of the disease, at global, regional and country levels. This is done in the context of global TB commitments, strategies and targets.

The 2024 edition of the report is, as usual, based primarily on data gathered by WHO from national ministries of health in annual rounds of data collection. In 2024, 193 countries and areas with more than 99% of the world’s population and TB cases reported data.

Was this page helpful? Give Feedback